14 September 2022

Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen's Scientific Board to support the development of AI platforms for cell therapy discovery.

Read more
#

Ardigen's feed news

Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen's Scientific Board to support the development of AI platforms for cell therapy discovery.
14 September 2022
Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen's Scientific Board to support the development of AI platforms for cell therapy discovery.
Read more
Łukasz Dutkiewicz, PhD has joined Ardigen as a Business Development Director
24 March 2022
Łukasz Dutkiewicz, PhD has joined Ardigen as a Business Development Director
Read more
Ardigen's Gene Regulation Platform
11 February 2022
Ardigen's Gene Regulation Platform
Boost your way to successful therapy. AI for Drug Discovery Days
28 January 2022
Boost your way to successful therapy. AI for Drug Discovery Days
Continue reading
Ardigen - new corporate identity
01 January 2022
Ardigen - new corporate identity
Continue reading
Merry Christmas 2021
24 December 2021
Merry Christmas 2021
Continue reading
Prof. Olivera Finn joined Ardigen’s Scientific Board to support the development of AI-driven technology platforms for cancer vaccines and cell therapies.
4th November 2021
Prof. Olivera Finn joined Ardigen’s Scientific Board to support the development of AI-driven technology platforms for cancer vaccines and cell therapies.
Continue reading
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
25 October 2021
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
Continue reading
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
7 september 2021
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Continue reading
Go up